NeuCyte Alternatives & Competitors
12 companies similar to NeuCyte — Decoding CNS Drug Discovery with SynFire® iP
Companies similar to NeuCyte
Cellular Dynamics International
Harness the Power of Fully Functional Human Cells for Innovative Drug Discovery and Therap...
StemoniX
Pre-plated, human iPSC-derived microOrgans for toxicology and drug discovery research
PsychoGenics
Discover Your Next Breakthrough
River BioMedics
River BioMedics paves the way to the future of cardiac drug discovery
Rival Readout
Competing with NeuCyte? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Emulate, Inc.
Our Organ-on-a-Chip technology provides a high-fidelity window into the inner workings of...
Newcells Biotech (Axol Bioscience)
The Newcells ophthalmology business was acquired by Axol Bioscience
Autifony Therapeutics
Autifony are dedicated to developing new medicines to treat rare genetic CNS disorders
CN Bio
Generate human-specific efficacy and safety data with PhysioMimix® microphysiological sys...
bit.bio
The Cell Coding Company
Altis Biosystems
Capturing the Complexity of the Human Gut
IRLAB Therapeutics AB
A clinical-stage biopharma discovering and developing novel treatments for the most troubl...
InSphero
Reliable, reproducible, and scalable 3D in vitro platforms for drug safety & efficacy test...
About NeuCyte
NeuCyte, founded in 2015 and headquartered in the United States, is pioneering advancements in the biotechnology sector with a focus on central nervous system (CNS) drug discovery. Their slogan, "Decoding CNS Drug Discovery with SynFire® iP," encapsulates their mission of refining preclinical testing methodologies. By...
Neural Cell Production, Assay Development, Functional Phenotypic Assessment, Custom iPSC-Derived Cell Production, Compound Screening
Biopharmaceutical Companies, Neurological Research Institutes, Medical Researchers, Pharmaceutical Firms, Biotech Startups Focusing on Neurological Conditions
CNS Drug Discovery, Neurological Disorders, Neural Cell Technology, Stem Cell Biology, Drug Development, Human Neural Platform, Neurotoxicity Testing, In Vitro Disease Modeling, Lead Compound Optimization, Preclinical Testing, Clinical Trials, Drug Efficacy, Scientific Advisory Board, Neurosciences
B2B, Platform, E Commerce
Project Based, Product Sales, Licensing
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around NeuCyte: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at NeuCyte on 14 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.